Outcomes of native tissue transvaginal apical approaches in women with advanced pelvic organ prolapse and stress urinary incontinence
- PMID: 32146521
- PMCID: PMC7483223
- DOI: 10.1007/s00192-020-04271-y
Outcomes of native tissue transvaginal apical approaches in women with advanced pelvic organ prolapse and stress urinary incontinence
Abstract
Introduction and hypothesis: Limited data exist comparing different surgical approaches in women with advanced vaginal prolapse. This study compared 2-year surgical outcomes of uterosacral ligament suspension (ULS) and sacrospinous ligament fixation (SSLF) in women with advanced prolapse (stage III-IV) and stress urinary incontinence.
Methods: This was a secondary analysis of a multicenter 2 × 2 factorial randomized trial comparing (1) ULS versus SSLF and (2) behavioral therapy with pelvic floor muscle training versus usual care. Of 374 subjects, 117/188 (62.7%) in the ULS and 113/186 (60.7%) in the SSLF group had advanced prolapse. Two-year surgical success was defined by the absence of (1) apical descent > 1/3 into the vaginal canal, (2) anterior/posterior wall descent beyond the hymen, (3) bothersome bulge symptoms, and (4) retreatment for prolapse. Secondary outcomes included individual success outcome components, symptom severity measured by the Pelvic Organ Prolapse Distress Inventory, and adverse events. Outcomes were also compared in women with advanced prolapse versus stage II prolapse.
Results: Success did not differ between groups (ULS: 58.2% [57/117] versus SSLF: 58.5% [55/113], aOR 1.0 [0.5-1.8]). No differences were detected in individual success components (p > 0.05 for all components). Prolapse symptom severity scores improved in both interventions with no intergroup differences (p = 0.82). Serious adverse events did not differ (ULS: 19.7% versus SSLF: 16.8%, aOR 1.2 [0.6-2.4]). Success was lower in women with advanced prolapse compared with stage II (58.3% versus 73.2%, aOR 0.5 [0.3-0.9]), with no retreatment in stage II.
Conclusions: Surgical success, symptom severity, and overall serious adverse events did not differ between ULS and SSLF in women with advanced prolapse. ClinicalTrials.gov Identifier: NCT01166373.
Keywords: Advanced prolapse; Pelvic organ prolapse; Prolapse repair; Sacrospinous ligament fixation; Uterosacral ligament suspension; Vaginal prolapse repair.
Similar articles
-
Five-year surgical outcomes of transvaginal apical approaches in women with advanced pelvic organ prolapse.Int Urogynecol J. 2023 Sep;34(9):2171-2181. doi: 10.1007/s00192-023-05501-9. Epub 2023 Apr 11. Int Urogynecol J. 2023. PMID: 37039859 Clinical Trial.
-
Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial.JAMA. 2018 Apr 17;319(15):1554-1565. doi: 10.1001/jama.2018.2827. JAMA. 2018. PMID: 29677302 Free PMC article. Clinical Trial.
-
Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial.JAMA. 2014 Mar 12;311(10):1023-34. doi: 10.1001/jama.2014.1719. JAMA. 2014. PMID: 24618964 Free PMC article. Clinical Trial.
-
Guideline No. 413: Surgical Management of Apical Pelvic Organ Prolapse in Women.J Obstet Gynaecol Can. 2021 Apr;43(4):511-523.e1. doi: 10.1016/j.jogc.2021.02.001. Epub 2021 Feb 3. J Obstet Gynaecol Can. 2021. PMID: 33548503
-
Surgery in urogynecology.Minerva Med. 2012 Feb;103(1):23-36. Minerva Med. 2012. PMID: 22278066 Review.
Cited by
-
Efficacy of Sacrospinous Fixation or Uterosacral Ligament Suspension for Pelvic Organ Prolapse in Stages III and IV: Randomized Clinical Trial.Rev Bras Ginecol Obstet. 2023 Oct;45(10):e584-e593. doi: 10.1055/s-0043-1772592. Epub 2023 Nov 9. Rev Bras Ginecol Obstet. 2023. PMID: 37944925 Free PMC article. Clinical Trial.
-
Postpartum Anorectal and Pelvic Floor Disorders: Evaluation, Treatment, and Prevention.Curr Gastroenterol Rep. 2025 Jul 3;27(1):48. doi: 10.1007/s11894-025-01000-7. Curr Gastroenterol Rep. 2025. PMID: 40608234 Free PMC article. Review.
-
A Modified McCall Culdoplasty in Pelvic Organ Prolapse Surgery: Anatomical and Functional Outcomes.Int Urogynecol J. 2024 Dec;35(12):2341-2348. doi: 10.1007/s00192-024-05886-1. Epub 2024 Aug 7. Int Urogynecol J. 2024. PMID: 39110177
-
Five-year surgical outcomes of transvaginal apical approaches in women with advanced pelvic organ prolapse.Int Urogynecol J. 2023 Sep;34(9):2171-2181. doi: 10.1007/s00192-023-05501-9. Epub 2023 Apr 11. Int Urogynecol J. 2023. PMID: 37039859 Clinical Trial.
-
Quality of life and its associated factors among women with pelvic organ prolapse who attend gynecology clinics Southern Ethiopia 2022.BMC Womens Health. 2024 Jul 12;24(1):398. doi: 10.1186/s12905-024-03238-1. BMC Womens Health. 2024. PMID: 38997642 Free PMC article.
References
-
- FDA, Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal mesh placement for pelvic organ prolapse. US Food and Drug Administration, 2011: p. US Food and Drug Administration; 2011.
-
- Boyles SH, Weber AM, and Meyn L, Procedures for pelvic organ prolapse in the United States, 1979–1997. Am J Obstet Gynecol, 2003. 188(1): p. 108–15. - PubMed
-
- Montoya TI, Grande KB, and Rahn DD, Apical vaginal prolapse surgery: practice patterns and factors guiding route of repair. Female Pelvic Med Reconstr Surg, 2012. 18(6): p. 315–20. - PubMed
-
- Denman MA, et al., Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol, 2008. 198(5): p. 555 e1–5. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- UG1 HD069013/HD/NICHD NIH HHS/United States
- UG1 HD069006/HD/NICHD NIH HHS/United States
- UG1 HD054241, UG1 HD041261, UG1 HD054214, UG1 HD041267, UG1 HD069010, UG1 HD069006, UG1 HD069013, U24 HD069031/Eunice Kennedy Shriver National Institute of Child Health and Human Development/International
- UG1 HD069010/HD/NICHD NIH HHS/United States
- U10 HD041267/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases